India Globalization Capital Regains NYSE American Listing Compliance

BETHESDA, Md., Nov. 10, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American: IGC) announced that it received a letter on November 9, 2017 from NYSE Regulation stating that it is in compliance with the NYSE American LLC continued listing standards set forth in Section 704 of the NYSE American Company Guide.  Specifically, IGC held an annual meeting on November 8, 2017. As is the case for all listed issuers, the Company’s continued listing eligibility will continue to be assessed on an ongoing basis.   

About IGCIGC is engaged in the development of cannabis based combination therapies to treat Alzheimer’s, pain, nausea, eating disorders, several end points of Parkinson’s, and epilepsy in dogs and cats.  IGC has assembled a portfolio of patent filings and four lead product candidates addressing these conditions. The company is based in Maryland, USA.

For more information please visit www.igcinc.us Follow us on Twitter @IGCIR and Facebook.com/IGCIR/ 

Forward-looking StatementsPlease see forward looking statements as discussed in detail in IGC's Form 10K for fiscal year ended March 31, 2017, and in other reports filed with the U.S. Securities and Exchange Commission.

Contact:Claudia Grimaldi301-983-0998

You May Also Be Interested In

• Mesoblast completes patient treatment in phase 3 back pain trial
• EMA validates Pfizer and Valneva's Lyme disease vaccine application
• SAGA Metals Reports Assays from R-0061 to R-0063 with Intercepts Including 47.36% Fe2O3, 6.73% TiO2, 0.353% V2O5 from 2026 Drilling at Radar Critical Minerals Project in Labrador